Kimia Biosciences [KIMIABL] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Kimia Biosciences

BSE

Sun Pharmaceutical

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Kimia Biosciences wins in 4 metrics, Sun Pharmaceutical wins in 10 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Kimia Biosciences	Sun Pharmaceutical	Better
P/E Ratio (TTM)	N/A	37.37	N/A
Price-to-Book Ratio	20.89	5.42	Sun Pharmaceutical
Debt-to-Equity Ratio	394.92	3.26	Sun Pharmaceutical
PEG Ratio	N/A	49.94	N/A
EV/EBITDA	12.86	24.15	Kimia Biosciences
Profit Margin (TTM)	8.08%	19.29%	Sun Pharmaceutical
Operating Margin (TTM)	19.09%	24.34%	Sun Pharmaceutical
EBITDA Margin (TTM)	19.09%	24.34%	Sun Pharmaceutical
Return on Equity	186.70%	15.08%	Kimia Biosciences
Return on Assets (TTM)	9.99%	11.87%	Sun Pharmaceutical
Free Cash Flow (TTM)	N/A	$119.44B	N/A
Dividend Yield	N/A	1.26%	N/A
1-Year Return	-15.06%	-8.55%	Sun Pharmaceutical
Price-to-Sales Ratio (TTM)	1.84	7.28	Kimia Biosciences
Enterprise Value	$2.58B	$3,703.82B	Sun Pharmaceutical
EV/Revenue Ratio	2.17	6.89	Kimia Biosciences
Gross Profit Margin (TTM)	N/A	79.58%	N/A
Revenue per Share (TTM)	$25	$224	Sun Pharmaceutical
Earnings per Share (Diluted)	N/A	$43.67	N/A
Beta (Stock Volatility)	1.14	0.31	Sun Pharmaceutical

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Kimia Biosciences vs Sun Pharmaceutical Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Kimia Biosciences	-4.99%	-20.79%	-35.33%	10.03%	-6.90%	-1.94%
Sun Pharmaceutical	-0.72%	-2.63%	-5.12%	-10.20%	-8.38%	-16.03%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Kimia Biosciences	-15.06%	10.69%	26.80%	120.00%	120.00%	120.00%
Sun Pharmaceutical	-8.55%	73.73%	198.65%	76.77%	806.33%	2,657.91%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Kimia Biosciences (KIMIABL): View Full Stock Overview

Sun Pharmaceutical (SUNPHARMA): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Kimia Biosciences vs Sun Pharmaceutical

Metric	KIMIABL	SUNPHARMA
Market Information
Market Cap i	₹2.19B	₹3.92T
Market Cap Category	Small cap	Large cap
10 Day Avg. Volume i	10,138	2,473,887
90 Day Avg. Volume i	24,617	2,177,422
Last Close	₹44.00	₹1,586.90
52 Week Range	₹35.10 - ₹86.85	₹1,553.05 - ₹1,960.35
% from 52W High	-49.34%	-19.05%
All-Time High	₹86.85 (Jul 02, 2025)	₹1,960.35 (Sep 30, 2024)
% from All-Time High	-49.34%	-19.05%
Growth Metrics
Quarterly Revenue Growth	0.26%	0.10%
Quarterly Earnings Growth	0.11%	-0.20%
Financial Health
Profit Margin (TTM) i	0.08%	0.19%
Operating Margin (TTM) i	0.19%	0.24%
Return on Equity (TTM) i	1.87%	0.15%
Debt to Equity (MRQ) i	394.92	3.26
Cash & Liquidity
Book Value per Share (MRQ)	₹2.11	₹300.99
Cash per Share (MRQ)	₹0.04	₹108.88
Operating Cash Flow (TTM) i	₹213.14M	₹110.84B
Levered Free Cash Flow (TTM) i	₹54.08M	₹109.29B
Dividends
Last 12-Month Dividend Yield i	N/A	1.26%
Last 12-Month Dividend i	N/A	₹21.00

Valuation & Enterprise Metrics Analysis: Kimia Biosciences vs Sun Pharmaceutical

Metric	KIMIABL	SUNPHARMA
Price Ratios
P/E Ratio (TTM) i	N/A	37.37
Forward P/E i	N/A	49.94
PEG Ratio i	N/A	49.94
Price to Sales (TTM) i	1.84	7.28
Price to Book (MRQ) i	20.89	5.42
Market Capitalization
Market Capitalization i	₹2.19B	₹3.92T
Enterprise Value i	₹2.58B	₹3.70T
Enterprise Value Metrics
Enterprise to Revenue i	2.17	6.89
Enterprise to EBITDA i	12.86	24.15
Risk & Other Metrics
Beta i	1.14	0.31
Book Value per Share (MRQ) i	₹2.11	₹300.99

Financial Statements Comparison: Kimia Biosciences vs Sun Pharmaceutical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	KIMIABL	SUNPHARMA
Revenue/Sales i	N/A	₹137.86B
Cost of Goods Sold i	N/A	₹28.15B
Gross Profit i	N/A	₹109.71B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	N/A	₹33.72B
EBITDA i	N/A	₹47.66B
Pre-Tax Income i	N/A	₹31.73B
Income Tax i	N/A	₹8.70B
Net Income (Profit) i	N/A	₹22.93B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	KIMIABL	SUNPHARMA
Cash & Equivalents i	N/A	₹102.69B
Total Current Assets i	N/A	₹526.24B
Total Current Liabilities i	N/A	₹181.94B
Long-Term Debt i	N/A	₹3.58B
Total Shareholders Equity i	N/A	₹724.86B
Retained Earnings i	N/A	₹578.62B
Property, Plant & Equipment i	N/A	₹100.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	KIMIABL	SUNPHARMA
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	KIMIABL	SUNPHARMA
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	10,138	2,473,887
Average Daily Volume (90 Day) i	24,617	2,177,422
Shares Outstanding i	47.31M	2.40B
Float Shares i	3.80M	1.04B
% Held by Insiders i	0.92%	0.56%
% Held by Institutions i	0.00%	0.25%

Dividend Analysis & Yield Comparison: Kimia Biosciences vs Sun Pharmaceutical

Metric	KIMIABL	SUNPHARMA
Last 12-Month Dividend i	N/A	₹21.00
Last 12-Month Dividend Yield i	N/A	1.26%
3-Year Avg Annual Dividend i	N/A	₹14.67
3-Year Avg Dividend Yield i	N/A	0.46%
3-Year Total Dividends i	N/A	₹44.00
Ex-Dividend Date	N/A	Jul 07, 2025

Kimia Biosciences [KIMIABL] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison